Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

March

15

Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms

ROCKAWAY, N.J.–(BUSINESS WIRE)–Mar. 15, 2021– Amid the vaccine rollout, 97,309 new cases of COVID-19...

11

electroCore Announces Fourth Quarter and Full Year 2020 Financial Results

Full year 2020 net sales of approximately $3.5 million increased 46% over $2.4 million for full year 2019;...

4

ATEC Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Highlights

U.S. Revenue Grows 38% in Fourth Quarter and 30% for Full Year Revenue Growth...

28

electroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia

Australian Therapeutic Goods Administration approved gammaCore Sapphire family of products ROCKAWAY, N.J., Feb. 28, 2021 (GLOBE NEWSWIRE)...

24

Non-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research

electroCore and the Hospital Clínico Universitario de Valencia have completed patient enrollment in SAVIOR-1 study ROCKAWAY,...

23

electroCore Announces Two-Year Extension of gammaCore™ Listing in the NHS Supply Chain Catalogue

Extension maintains listing through June 3, 2023 ROCKAWAY, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) — electroCore,...

16

electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Adolescent Migraine

FDA clearance expands gammaCore label to include the acute and preventive treatment of migraine...

11

electroCore Announces Completion of Enrollment in SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in COVID-19 Patients Exhibiting Respiratory Symptoms

Spain-based study has enrolled 110 patients over 18 years of age with respiratory failure...

9

electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Reduce Ileus After Major Colorectal Surgery

UK-based study enrolled forty subjects and was undertaken to explore the safety and feasibility...

9

TriSalus Life Sciences Receives Expanded Reimbursement Authorization from CMS for TriNav Infusion System

Transitional Pass Through Payment (TPT) Facilitates Patient Access to New and Innovative Products That...

2

electroCore Announces Full Enrollment of TR-VENUS study of Non-Invasive Vagal Nerve Stimulation (nVNS) for the Acute Treatment of Stroke

Primary objective to assess the safety of nVNS in the setting of acute stroke...

1

ATEC Opens New Headquarters With Substantially Increased Sales And Surgeon Education Capacity

120,000 square-foot facility includes a world-class cadaveric lab, a state-of-the-art machining center, an extensive...

Recent developments

News

March

15

Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms

March

11

electroCore Announces Fourth Quarter and Full Year 2020 Financial Results

March

4

ATEC Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Highlights

February

28

electroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia

February

24

Non-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research

February

23

electroCore Announces Two-Year Extension of gammaCore™ Listing in the NHS Supply Chain Catalogue

February

16

electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Adolescent Migraine

February

11

electroCore Announces Completion of Enrollment in SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in COVID-19 Patients Exhibiting Respiratory Symptoms

February

9

electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Reduce Ileus After Major Colorectal Surgery

February

9

TriSalus Life Sciences Receives Expanded Reimbursement Authorization from CMS for TriNav Infusion System

February

2

electroCore Announces Full Enrollment of TR-VENUS study of Non-Invasive Vagal Nerve Stimulation (nVNS) for the Acute Treatment of Stroke

February

1

ATEC Opens New Headquarters With Substantially Increased Sales And Surgeon Education Capacity